The use of disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis
Citation
AIHW
Australian Institute of Health and Welfare (2011) The use of disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis, AIHW, Australian Government, accessed 19 March 2024.
APA
Australian Institute of Health and Welfare. (2011). The use of disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis. Canberra: AIHW.
MLA
Australian Institute of Health and Welfare. The use of disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis. AIHW, 2011.
Vancouver
Australian Institute of Health and Welfare. The use of disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis. Canberra: AIHW; 2011.
Harvard
Australian Institute of Health and Welfare 2011, The use of disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis, AIHW, Canberra.
PDF | 772Kb
Disease and modifying anti-rheumatic drugs (DMARDs) are now considered first-line treatment for rheumatoid arthritis (RA). When initiated early, they have been shown to alter the disease course and reduce joint erosion, reducing or preventing disability and improving quality of life.
- ISSN: 1833-0991
- ISBN: 978-1-74249-133-2
- Cat. no: PHE 138
- Pages: 58